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The steroid 17b-estradiol (E2) is well known to
influence hippocampal functions such as memory,
affective behaviors, and epilepsy. There is growing
awareness that in addition to responding to ovarian
E2, the hippocampus of both males and females
synthesizes E2 as a neurosteroid that could acutely
modulate synaptic function. Previous work on acute
E2 actions in the hippocampus has focused on
excitatory synapses. Here, we show that E2 rapidly
suppresses inhibitory synaptic transmission in
hippocampal CA1. E2 acts through the a form of
the estrogen receptor to stimulate postsynaptic
mGluR1-dependent mobilization of the endocanna-
binoid anandamide, which retrogradely suppresses
GABA release from CB1 receptor-containing inhibi-
tory presynaptic boutons. Remarkably, this effect
of E2 is sex specific, occurring in females but not in
males. Acute E2 modulation of endocannabinoid
tone and consequent suppression of inhibition
provide a mechanism by which neurosteroid E2
could modulate hippocampus-dependent behaviors
in a sex-specific manner.
INTRODUCTION
Estrogens influence hippocampal function through multiple
mechanisms with time courses ranging from minutes to days.
Recent recognition that a key estrogen, 17b-estradiol (E2), is
produced as a neurosteroid in the brains of both males and
females has fueled a resurgence of interest in acute nongenomic
estrogen signaling (Woolley, 2007). Many hippocampal neurons
express the E2-synthesizing enzyme P450 aromatase (Hojo
et al., 2004), which could provide a source of locally generated
E2 to acutely modulate synaptic function in vivo.
E2 applied to hippocampal slices rapidly potentiates synapti-
cally evoked field excitatory postsynaptic potentials (EPSPs) in
the CA1 region (Teyler et al., 1980), as well as intracellularly
recorded EPSPs (Wong and Moss, 1992) and excitatory post-
synaptic currents (EPSCs) (Smejkalova and Woolley, 2010) in
CA1 pyramidal cells. On the one hand, E2 appears to act onexcitatory synapses through the b form of the classical estrogen
receptor (ERb). ERb agonists rapidly increase AMPA receptor
(AMPAR)-mediated field EPSPs (Krama´r et al., 2009) and EPSCs
(Smejkalova and Woolley, 2010), whereas ERa agonists do not
affect AMPAR-mediated responses. On the other hand, E2-
induced potentiation of field EPSPs is reduced in ERa knockout
compared to wild-type mice (Fugger et al., 2001), suggesting
a more complex action of E2. One possibility is that E2 acutely
potentiates excitatory synapses via ERb and simultaneously
suppresses inhibitory synapses via ERa.
To investigate acute modulation of inhibitory synapses, we re-
corded GABAA receptor-mediated inhibitory postsynaptic
currents (IPSCs) in CA1 pyramidal cells with application of E2
to hippocampal slices from adult female rats. We found that, in
a subset of cells, E2 rapidly suppresses IPSCs. Subsequent
studies indicated that E2-induced IPSC suppression depends
on ERa- and mGluR1-dependent mobilization of endocannabi-
noids to decrease the probability of GABA release from CB1R-
containing inhibitory synaptic inputs. Additionally, E2-induced
suppression of IPSCs occurred in females but not in males.
These results show that sex steroids can rapidly regulate inhibi-
tory synaptic transmission in the hippocampus through a sex-
specific mechanism.RESULTS
Estradiol Acutely Suppresses a Subset of Inhibitory
Inputs through an ERa-Dependent Decrease
in the Probability of GABA Release
We investigated whether E2 acutely affects perisomatic IPSCs
in hippocampal CA1 pyramidal cells of adult female rats. Based
on stimulus-response curves (Figures 1A and 1B), recordings
were classified as unitary IPSCs or as compound IPSCs arising
from activation of multiple inhibitory afferents. Pairs of IPSCs
were recorded before, during, and after 10 min application of
1, 10, or 100 nM E2 to each slice. In 17 of 31 cells (55%), 10 or
100 nM E2 rapidly suppressed inhibitory synaptic transmission,
evidenced by decreased IPSC amplitude and increased paired-
pulse ratio (PPR). The remaining 14 cells showed no response to
10 or 100 nM E2, and none of 6 cells tested with 1 nM E2 showed
any response. As evident in Figure 1C, there were two distinct
classes of E2 response: moderate or robust suppression of
IPSCs. E2 moderately suppressed IPSCs (range 25%–43%) in
9 of 17 E2-responsive cells, whereas in the other 8, E2 robustlyNeuron 74, 801–808, June 7, 2012 ª2012 Elsevier Inc. 801
Figure 1. E2 Acts through ERa to Acutely Suppress GABA Release at a Subset of Inhibitory Synapses
(A and B) Stimulus-response curveswere used to identify compound (A) versus unitary (B) IPSCs. Open symbols are individual sweeps; filled symbols are average
of four sweeps at each stimulus intensity. (C) Normalized IPSC amplitude changes with 1 nM (n = 6), 10 nM (n = 14), or 100 nM (n = 17) E2 showing that E2
suppresses IPSCs robustly, moderately, or not at all. Square symbols are data for compound IPSCs; triangles are data for unitary IPSCs (also in E, F, H, I, K, L, N,
and O). (D) Recording of E2-sensitive compound IPSCs showing individual traces and time course of the E2-induced decrease in IPSC amplitude (100 nM E2).
Each point is an individual sweep, and SR 95531 (SR, 2 mM) applied at the end of the experiment blocked IPSCs (also in G, J, and M). (E) Group compound IPSC
amplitude data for all experiments as in (D) (n = 6). Connected open symbols are individual cells; filled symbols are mean ± SEM for all cells (also in F, H, I, K, L, N,
and O). (F) Group PPR data for the same cells as in (E). **p < 0.01, paired t test (also in I, L, and O). (G) Recording of E2-sensitive unitary IPSCs showing individual
traces and time course (100 nM E2). (H) Group unitary IPSC amplitude data for all experiments as in (G) (n = 4). (I) Group PPR data for the same cells as in (H). (J)
Recording of PPT (ERa agonist, 200 nM)-sensitive IPSCs showing individual traces and time course. PPTmimicked and occluded E2-induced IPSC suppression.
(K) Group amplitude data for all experiments as in (J) (n = 8). (L) Group PPR data for the same cells as in (K). (M) Recording of E2-sensitive IPSCs tested with DPN
(ERb agonist, 500 nM). DPN did not affect E2-sensitive IPSCs. Scale bar indicates 25 pA, 25ms and also applies to (D), (G), and (J). (N) Group IPSC amplitude data
for all experiments as in (M) (n = 6). (O) Group PPR data for the same cells as in (N).
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Estradiol Acutely Suppresses Synaptic Inhibitionsuppressed IPSCs (range 71%–77%). Cells classified as
showing no response to E2 ranged from a 6% decrease to
a 9% increase in IPSC amplitude. Based on this distribution,
we used a 25% decrease in amplitude as the threshold for iden-
tifying E2-responsive IPSCs.
Most recordings were of compound IPSCs (Figures 1D–1F). In
6 of 11 cells, 100 nM E2 decreased compound IPSC amplitude
by 44%±8% (range 25%–72%; Figure 1E), whichwas paralleled
by an increase in PPR from 0.79 ± 0.05 to 1.21 ± 0.07 (paired
t test, p < 0.001; Figure 1F). Thus, in addition to decreasing
IPSC amplitude, E2 converted inhibitory synapses from
depressing (PPR < 1.0) to facilitating (PPR > 1.0). Results were
similar for unitary IPSCs, except that an E2 response, when it
occurred, was consistently robust (Figure 1G). In 4 E2-respon-
sive unitary IPSC recordings, E2 decreased IPSC amplitude by
73% ± 2% (range 68%–77%; Figure 1H) and increased PPR
from 0.80 ± 0.06 to 1.31 ± 0.12 (paired t test, p < 0.01; Figure 1I).
Results with 10 nM E2 were similar. In 7 of 14 cells, 10 nM E2
decreased IPSC amplitude by 47% ± 7% (range 29%–74%). In
cells classified as showing no IPSC amplitude response to
10 nM or 100 nM E2, PPR also was unaffected (0.71 ± 0.05
versus 0.70 ± 0.07). There was no apparent relationship between
initial release probability and the likelihood of a response to E2.
Initial PPR of E2-sensitive IPSCs was 0.76 ± 0.03, not different
from the 0.75 ± 0.03 initial PPR in E2-insensitive IPSCs. Likewise,
among E2-sensitive IPSCs, there was no relationship between
initial PPR and themagnitude of response to E2. For all E2-sensi-
tive IPSCs, the E2-induced changes in IPSC amplitude and PPR
occurred rapidly, beginning within 2–3 min, and were not readily
reversible. Application of the GABAA receptor antagonist SR
95531 at the end of each experiment confirmed that IPSCs
were GABAA receptor mediated.
Together, these results demonstrated that E2 rapidly
suppresses inhibitory synaptic transmission at a subset of peri-
somatic inputs to CA1 pyramidal cells and acts, at least in
part, by decreasing the probability of GABA release. Unitary
IPSCs showed either robust suppression or none at all, indi-
cating that only a subset of inhibitory inputs is sensitive to E2
and that E2 can profoundly suppress synaptic transmission at
individual connections. Moderate suppression of compound
IPSCs probably arises from a mixture of robust suppression at
some synapses contributing to the IPSC and no effect at other
synapses in the same IPSC. Compound IPSCs that showed
robust suppression probably contained mostly E2-sensitive
synapses and few E2-insensitive ones.
Experiments with ER subtype selective agonists, PPT for ERa
and DPN for ERb, showed that ERa mediates E2-induced
suppression of inhibition. Concentrations of PPT and DPN
were chosen to match the relative binding affinities of 100 nM
E2. The ERa agonist PPT (200 nM) mimicked and occluded
E2-induced IPSC suppression and increased PPR (Figure 1J).
In 8 of 13 cells (62%), PPT rapidly decreased IPSC amplitude
by 65% ± 3%, and E2 application after PPT produced no further
suppression (Figure 1K). PPT also increased PPR from 0.80 ±
0.04 to 1.13 ± 0.06 (paired t test, p < 0.01; Figure 1L). In the
5 cells in which IPSC amplitude was not affected by PPT
(5% ± 2%), PPR also was unchanged. Two of 8 PPT-responsive
recordings were of unitary IPSCs, in which PPT decreased IPSCamplitude by 65% and 77%. In contrast to PPT, the ERb agonist
DPN (500 nM) failed to affect IPSCs in any of 12 cells. In 6 record-
ings with DPN, E2 applied after DPN suppressed IPSCs, con-
firming their E2 sensitivity. DPN alone produced negligible
changes in IPSC amplitude (5% ± 3%) and PPR, whereas E2
applied after DPN decreased IPSC amplitude by 50% ± 6%
and increased PPR from 0.94 ± 0.05 to 1.33 ± 0.09 (paired t
test, p < 0.01; Figures 1M–1O). Two of 6 E2-responsive DPN
recordings were of unitary IPSCs, both of which showed
a 64% E2-induced decrease in amplitude.
Estradiol-Induced Suppression of Inhibition Requires
CB1 Receptor Activation
A subset of perisomatic inhibitory axonal boutons in CA1
contains CB1Rs that mediate suppression of GABA release by
retrograde endocannabinoid signaling (Katona et al., 1999), as
occurs in depolarization-induced suppression of inhibition
(DSI; Wilson and Nicoll, 2001) and long-term depression of inhi-
bition (I-LTD; Chevaleyre and Castillo, 2003). We found that
E2-induced IPSC suppression also requires CB1Rs. Blocking
CB1Rs with AM251 (AM, 10 mM) increased IPSC amplitude in
10 of 27 cells (37%), indicating tonic endocannabinoid-mediated
suppression of inhibition. The effect of AM was reversible within
20 min. In 7 experiments, we applied E2 twice, first after
establishing a new stable (higher) baseline in AM and then again
after reestablishing the original baseline after AM washout (Fig-
ure 2A). E2 (100 nM) had no effect on IPSC amplitude (5% ±
3%) or PPR in the presence of AM. In 6 cells (86%), application
of E2 after AMwashout decreased IPSC amplitude by 43%± 4%
(Figure 2B), confirming E2-sensitivity of IPSCs. E2-induced IPSC
suppression after AMwashout was paralleled by increased PPR,
from 0.90 ± 0.03 to 1.04 ± 0.04 (paired t test, p < 0.05). In the 1
cell classified as not responding to E2 after AM washout, E2
tended to decrease IPSC amplitude but only by 15%. In the
other 3 recordings of AM-sensitive IPSCs, we applied E2 after
the AM-induced increase was established and continued AM
throughout the experiment. As before, E2 failed to affect IPSC
amplitude (3% ± 4%) or PPR in the presence of AM.
In 17 cells in which AM did not affect IPSCs, we applied E2
in the presence of AM and either washed both from the slice
simultaneously (6 cells) or continued E2 for 10 additional min
after AM washout (11 cells). As before, E2 never affected IPSC
amplitude (1% ± 2%) or PPR in the presence of AM. In 9 of 11
cells in which we continued E2 after AM washout, IPSC ampli-
tude remained unchanged in E2 (1% ± 3%), indicating that these
were not E2-sensitive IPSCs. In the other 2 cells (18%), E2
decreased IPSC amplitude by 56% and 38% once AM was
washed out. Together, these experiments demonstrated that in-
hibiting CB1Rs with AM blocks E2-induced IPSC suppression
and that while E2 can affect both AM-sensitive and -insensitive
IPSCs, AM-sensitive IPSCs are more likely to respond to E2
(86% versus 18%).
To corroborate results with AM, we applied the CB1R agonist
WIN 55,212-2 (WIN, 5 mM; Figure 2C). WIN rapidly suppressed
IPSCs and increased PPR in 11 of 12 (92%) cells, indicating
that most recordings involved at least some CB1R-containing
synapses. The WIN-induced decrease in IPSC amplitude
was 59% ± 5%, and WIN increased PPR from 0.76 ± 0.02 toNeuron 74, 801–808, June 7, 2012 ª2012 Elsevier Inc. 803
Figure 2. Estradiol-Induced IPSC Suppression
Requires CB1Rs for Induction, but Not Mainte-
nance
(A) Recording of AM251 (CB1R antagonist, AM, 10 mM)-
sensitive IPSCs in which E2 was applied in the presence
and then absence of AM; individual traces and time course
are shown. Each point is an individual sweep and SR
95531 (SR, 2 mM) applied at the end of the experiment
blocked IPSCs (also in C and E). Dotted line shows
average IPSC amplitude during 2 min before the second
E2 application. AM blocked E2-induced IPSC suppres-
sion. (B) Group IPSC amplitude data for all experiments as
in (A) (n = 6). Connected open symbols are individual cells;
filled symbols aremean ± SEM for all cells (also in D and F).
(C) Recording of WIN 55,212-2 (CB1R agonist, WIN,
5 mM)-sensitive IPSCs; individual traces and time course
are shown. WIN occluded E2-induced IPSC suppression.
(D) Group IPSC amplitude data for all experiments as in (C)
(n = 11). (E) Recording of E2-sensitive IPSCs in which AM
was applied after the E2-induced decrease in IPSC
amplitude was established; individual traces and time
course are shown. AM applied after E2 washout had no
effect on IPSCs. Scale bar indicates 50 pA, 25ms and also
applies to (A) and (C). (F) Group IPSC amplitude data for all
experiments as in (E) (n = 6).
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Estradiol Acutely Suppresses Synaptic Inhibition1.02 ± 0.07. Importantly, E2 applied in the presence of WIN
induced no further suppression of IPSCs (3% ± 1%; Figure 2D)
or change in PPR (also 1.02 ± 0.07). Thus, CB1R activation by
WIN fully occluded E2’s effects on IPSCs, confirming that E2-
induced suppression of inhibition requires CB1Rs. To test
whether CB1Rs are necessary for maintenance of E2-induced
IPSC suppression, we applied AM following E2 washout, after
IPSC suppression was established (Figure 2E). In 6 of 6 cells,
E2 decreased IPSC amplitude by 48% ± 4%, and AM applied
after E2 had no further effect on IPSC amplitude (8% ± 4%; Fig-
ure 2F) or PPR. Thus, acute suppression of inhibition by E2
requires CB1Rs for induction, but not maintenance.
Roles of 2-Arachidonoylglycerol versus Anandamide in
Estradiol-Induced IPSC Suppression
Results with AM and WIN suggested that E2 suppresses inhibi-
tion by mobilizing endocannabinoids. There are two predomi-
nant endocannabinoids that act at GABAergic synapses in
CA1 to suppress inhibitory synaptic transmission, 2-arachido-
noylglycerol (2-AG) and anandamide (also called N-arachido-
noylethanolamide or AEA). 2-AG and AEA are synthesized either
tonically or on demand, and their levels are tightly regulated by
distinct enzymatic pathways, which provides a way to investi-
gate the roles of each in modulating synaptic transmission.
First, we tested whether E2 could suppress IPSCs in the
presence of the diacylglycerol lipase (DGL) inhibitor tetrahydro-
lipstatin (THL, 10 mM), which inhibits synthesis of 2-AG and
consequently blocks DSI when bath applied (Hashimotodani
et al., 2008). For each cell, we tested DSI before and after
applying THL to confirm inhibition of 2-AG synthesis. In 4 of
9 cells (44%), THL increased IPSC amplitude, consistent with804 Neuron 74, 801–808, June 7, 2012 ª2012 Elsevier Inc.relief from tonic 2-AG-mediated suppression; in the remaining
5 cells, THL alone had no effect. In 6 of 9 (67%) cells, both
THL-sensitive (4 cells; Figures 3A and 3B) and THL-insensitive
(2 cells; data not shown) E2 (100 nM) decreased IPSC amplitude
in the presence of THL by 59% ± 7% (Figure 3B). We confirmed
that DSI was blocked by THL, indicating inhibition of 2-AG
synthesis, before E2 was applied (Figure 3C). Thus, inhibiting
2-AG synthesis failed to block E2-induced IPSC suppression,
a first indication that 2-AG is not required for E2-induced
suppression of IPSCs.
There is no selective inhibitor of AEA synthesis available. As
an alternative, we compared the effect of blocking breakdown
of AEA versus 2-AG using selective inhibitors of fatty acid
amide hydrolase (FAAH, for AEA) or monoacylglycerol lipase
(MGL, for 2-AG). Because such inhibitors increase levels of
their respective endocannabinoids, we reasoned that inhibition
of endocannabinoid degradation might occlude E2’s ability to
suppress IPSCs. The FAAH inhibitor URB 597 (URB, 1 mM)
decreased IPSC amplitude in 11 of 14 (79%) cells by 47% ±
4% (Figures 3D and 3E), indicating tonic accumulation of
AEA, whereas in the remaining 3 cells, URB had no effect.
Importantly, E2 (100 nM) applied in the presence of URB
induced no further decrease in IPSC amplitude (4% ± 2%;
Figure 3E), indicating that inhibition of FAAH completely
occluded E2-induced IPSC suppression. Similarly, E2 had
no effect on IPSC amplitude in the 3 URB-insensitive cells
(1% ± 4%). Consistent with the role of 2-AG rather than AEA
in mediating DSI in the hippocampus (Kim and Alger, 2004;
Pan et al., 2009), DSI was unaffected by URB (Figure 3F). These
findings suggested that AEA mediates E2-induced IPSC
suppression.
Figure 3. Estradiol-Induced IPSC Suppression Is Mediated by AEA,
Not 2-AG
(A) Recording of THL (DGL inhibitor, 10 mM)-sensitive IPSCs showing individual
traces and time course. Each point is an individual sweep, and SR 95531 (SR,
2 mM) applied at the end of the experiment blocked IPSCs (also in D and G).
THL did not block E2-induced IPSC suppression. (B) Group IPSC amplitude
data for experiments as in (A) (n = 4). Connected open symbols are individual
cells; filled symbols aremean ± SEM for all cells (also in E andH). (C) DSI tested
before (filled symbols) and in the presence of (open symbols) THL confirmed
that DSI was blocked before E2 application. Points are mean ± SEM for all E2-
responsive THL experiments. (D) Recording of URB 597 (FAAH inhibitor, URB,
1 mM)-sensitive IPSCs showing individual traces and time course. URB
occluded E2-induced suppression of IPSCs. (E) Group IPSC amplitude data
for all experiments as in (D) (n = 11). Compound IPSCs (squares) and unitary
IPSCs (triangles) are plotted together (also in H). (F) DSI tested before (filled
symbols) and in the presence (open symbols) of URB confirmed that DSI was
not affected by URB. Points are mean ± SEM for all experiments in (E). (G)
Recording of JZL 184 (MGL inhibitor, JZL, 100 nM)-sensitive IPSCs showing
individual traces and time course. Dotted line shows average IPSC amplitude
during 2 min before E2 application. JZL did not occlude E2-induced IPSC
suppression. Scale bar indicates 25 pA, 25 ms (50 pA, 25 ms in A and D). (H)
Group IPSC amplitude data for all experiments as in (G) (n = 9). (I) DSI tested
before (filled symbols) and in the presence (open symbols) of JZL before E2
application showed that the decay of DSI was prolonged in JZL. Points are
mean ± SEM for all experiments in (H).
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formed analogous experiments with the MGL inhibitor JZL 184
(JZL, 100 nM), which blocks breakdown of 2-AG (Pan et al.,
2009). Because inhibition of 2-AG synthesis by THL failed to
block E2-induced IPSC suppression, we hypothesized that
inhibiting 2-AG breakdown with JZL would fail to occlude E2-
induced IPSC suppression. In 13 of 16 cells (81%), JZL
decreased IPSC amplitude by 37% ± 3% (Figures 3G and 3H).
Once a stable baseline in JZL was established (40 min), we
applied E2 (100 nM) to determine whether further IPSC suppres-
sion was possible. In contrast to results with URB, E2 applied in
the presence of JZL decreased IPSC amplitude by 49% ± 5% in
9 of 16 cells (Figure 3H), almost identical to the effect of E2
alone. The remaining 7 cells, 4 JZL sensitive and 3 JZL insensi-
tive, showed no effect of E2 (1%± 3%). Consistent with accumu-
lation of 2-AG (Pan et al., 2009), JZL prolonged the time course of
DSI (Figure 3I). Thus, together with results using the 2-AG
synthesis inhibitor THL, JZL experiments confirmed that 2-AG
plays little to no role in E2-induced suppression of IPSCs.
Comparing the complete occlusion of E2-induced IPSC
suppression by inhibition of AEA breakdown with URB to the
lack of occlusion by inhibition of 2-AG breakdown with JZL,
these results strongly suggest that AEA mediates E2-induced
IPSC suppression.
Estradiol-Induced IPSC Suppression Requires mGluR1
and Is Sex Specific
E2-induced IPSC suppression resembles I-LTD more than DSI
in that brief E2 exposure produces a lasting decrease in IPSC
amplitude that depends on CB1Rs for induction but not mainte-
nance. I-LTD is typically induced by trains of stimuli delivered
to the str. radiatum; glutamate released during the train activates
postsynaptic mGluRs that are coupled to endocannabinoid
synthesis (Chevaleyre and Castillo, 2003). Our experi-
ments, however, involved neither trains nor stimulation in theNeuron 74, 801–808, June 7, 2012 ª2012 Elsevier Inc. 805
Figure 4. E2-Induced IPSC Suppression Requires
Postsynaptic mGluR1 and Is Sex Specific
(A) Recording of E2-sensitive IPSCs in which E2 was
applied in the presence and then absence of JNJ
16259685 (mGluR1 antagonist, JNJ, 0.2 mM); individual
traces and time course are shown. Each point is an indi-
vidual sweep and SR 95531 (SR, 2 mM) applied at the end
of the experiment blocked IPSCs (also in C and E). JNJ
blocked E2-induced IPSC suppression. (B) Group ampli-
tude data for all experiments as in (A) (n = 6). Connected
open symbols are individual cells; filled symbols are
mean ± SEM for all cells (also in D and F). (C) Recording of
IPSCs with GDPbS in the recording pipette showing indi-
vidual traces and time course. E2 had no effect on IPSCs
with postsynaptic G protein signaling blocked by GDPbS.
(D) Group IPSC amplitude data for all experiments as in (C)
(n = 10). (E) Recording of IPSCs in a male tested with
100 nM E2 showing individual traces and time course. E2
did not affect IPSCs. Scale bar indicates 50 pA, 25 ms
(also in A and C). (F) Group IPSC amplitude data for all but
one recording in males. E2 (10 nM, n = 7 or 100 nM, n = 15)
had no effect on IPSC amplitude in 22 of 23 cells. In one
recording not represented here, E2 produced a rapidly
reversible decrease in IPSC amplitude.
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absence of released glutamate? Mermelstein and colleagues
have shown in cultured hippocampal neurons that E2 can bind
a membrane form of ERa to acutely activate mGluR1 in the
absence of released glutamate (Boulware et al., 2005). To inves-
tigate whether a similar mechanism is involved in E2-induced
suppression of inhibition, we tested whether mGluR1 and
mGluR5 antagonists can inhibit E2-induced IPSC suppression.
The mGluR1 antagonist JNJ 16259685 (JNJ, 0.2 mM)
completely blocked E2-induced IPSC suppression (Figure 4A).
In 6 of 11 cells (55%), E2 had no effect on IPSCs in the presence
of JNJ (2% ± 2%) but then decreased IPSC amplitude by 52% ±
5% after JNJ washout (Figure 4B). The remaining 5 cells
recorded with JNJ were not E2 responsive (7% ± 2%). The
combination of JNJ and the mGluR5 inhibitor MPEP (40 mM),
or the mGluR1/5 inhibitor CPCCOEt alone (100 mM), also
blocked E2-induced IPSC suppression. In 6 cells, E2 had no
effect on IPSC amplitude in JNJ + MPEP (2% ± 1%) but
decreased IPSC amplitude by 52% ± 7% after washout. Simi-
larly, E2 had no effect on IPSC amplitude in 4 cells recorded
in CPCCOEt (3% ± 3%) but decreased IPSC amplitude by
47% ± 7% after washout. In contrast to JNJ, MPEP alone
did not block E2-induced IPSC suppression. In 3 cells, E2
decreased IPSC amplitude by 65% ± 4% in the presence of
MPEP. Thus, inhibiting mGluR1, but not mGluR5, blocks E2-
induced IPSC suppression. To investigate whether E2-induced
IPSC suppression depends on pre- or postsynaptic mGluR1,
we tested whether E2 could suppress IPSCs with postsynaptic
G protein signaling blocked by GDPbS in the recording pipette
(Figure 4C). E2 (100 nM) had no effect on IPSC amplitude in806 Neuron 74, 801–808, June 7, 2012 ª2012 Elsevier Inc.any of 10 GDPbS-loaded cells (0.7% ± 1.7%;
Figure 4D), strongly suggesting that the
mGluR1 required to induce IPSC suppression
is postsynaptic.One unusual feature of the E2-ERa-mGluR1 interaction
demonstrated by Boulware et al. (2005) is that it occurs only in
cultures derived from female rat pups and not from males.
Because E2-induced IPSC suppression appeared to depend
on a similar mechanism, we asked whether this effect of E2 is
also sex specific (Figure 4E). In 23 cells recorded from males,
E2 had no effect on IPSC amplitude (Figure 4F) or PPR in any
of 15 cells tested with 100 nM E2 or in 7 of 8 cells with 10 nM
E2. Whether males were gonadally intact (17 cells, 4% ± 1%)
or castrated (5 cells, 1% ± 3%) did not affect the results. By
contrast, the same concentrations of E2 decreased IPSC
amplitude and increased PPR in 55% of cells in females (Fig-
ure 1). In 1 male cell, 10 nM E2 did decrease IPSC amplitude
by 26%, but the effect reversed quickly upon E2 washout; in
females, IPSC amplitude always remained low after E2 washout.
These results show that acute E2-induced IPSC suppression
occurs much more often in females than in males. In the rare
instances in which E2 does affect IPSCs in males, this occurs
through a distinct mechanism.
DISCUSSION
We show here that E2 acutely suppresses synaptic inhibition
in the hippocampus through a sex-specific mechanism. E2
activates ERa-mGluR1-dependent mobilization of AEA,
which decreases the probability of GABA release at a subset
of CB1R-containing presynaptic inputs. More cells were respon-
sive to the CB1R agonist WIN (92%) than to E2 (55%), indicating
that the presence of ERa, mGluR1, and the appropriate coupling
between them are likely to be limiting factors that determine
Neuron
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E2 could be robust, up to a 77% reduction in unitary IPSC
amplitude, was initiated within a few minutes, and was not
readily reversible. Our findings demonstrate that E2 acutely
regulates synaptic inhibition in the hippocampus and show that
endogenous AEA can be mobilized in the hippocampus to
activate CB1R-dependent plasticity of inhibitory synapses.
Acute modulation of inhibition may be an important mediator of
neurosteroid E2 actions.
That E2 acts though AEA and not 2-AG to modulate inhibition
was surprising because other types of acute CB1R-dependent
signaling in the hippocampus, such as in DSI and I-LTD, are
mediated by 2-AG (Chevaleyre and Castillo, 2003; Kim and
Alger, 2004; Pan et al., 2009). The main distinction between
our experiments and previous studies is that we used females.
That we studied females may also explain why other studies
with males have not seen evidence of tonic AEA mobilization
(Kim and Alger, 2004), which we did observe, or an effect of E2
on field IPSPs (Krama´r et al., 2009). These contrasts point to
substantial differences between males and females in modula-
tion of synaptic function in the hippocampus.
The dependence of E2-induced IPSC suppression on
postsynaptic G protein signaling strongly suggests that E2
activates a postsynaptic ERa-mGluR interaction to stimulate
AEA mobilization. This does not rule out presynaptic E2
action as well, however. Extranuclear ERa is found in periso-
matic axonal boutons in CA1, particularly of CCK-containing
inhibitory interneurons (Hart et al., 2007), which are also those
that contain CB1Rs (Katona et al., 1999). Whether sex
differences in pre- and/or postsynaptic extranuclear ERa
signaling (Romeo et al., 2005) contribute to the lack of E2 effect
in males remains to be determined. Comparing the levels,
distribution, and function of each step in the pathway(s)
leading from E2 activation of extranuclear ERa to modulation
of GABA release in both males and females may point to
which of the many signaling pathways acutely activated by
E2 are relevant to acute suppression of inhibitory synaptic
transmission.
E2 is well known to influence hippocampal functions such as
memory and affective behaviors that differ between the sexes
(Gillies and McArthur, 2010), as well as neurological disorders
that involve the hippocampus such as temporal lobe epilepsy
(Guille et al., 2008). Most behavioral studies have examined
effects of E2 in females and on a timescale corresponding to
ovarian E2 fluctuations, which is much slower than the acute
suppression of inhibition that we report here. In addition, the
concentrations of E2 required for acute suppression of IPSCs,
10–100 nM, are higher than peak circulating levels (100 pM),
indicating that inhibitory synapses are likely to be protected
from acute modulation by relatively slow and low amplitude
fluctuations in ovarian E2. In contrast, neurosteroid E2 is report-
edly 5–10 nM on average (Hojo et al., 2009), probably higher
near sites of aromatase activity, and its synthesis may be activity
dependent (Hojo et al., 2004). Thus, neurosteroid E2 could
provide a localized source of E2 to acutely modulate synaptic
inhibition in vivo. A better understanding of sex-specific synaptic
modulation in the hippocampus and how E2 acutely regulates
endocannabinoid tone in females may point to targets for noveltherapies to combat neurological or mental health disorders
that differ between the sexes.
EXPERIMENTAL PROCEDURES
Animals were adult female (ovariectomized) or male (castrated or gonadally
intact) rats. Using standard methods, hippocampal slices were prepared
and whole-cell voltage-clamp recordings were made at 34C–35C with a
K-gluconate-based internal solution. For more information, see Supplemental
Experimental Procedures available online. Of note, E2 modulation of IPSCs
was never observed when recording with a CsCl-based internal solution,
possibly owing to interference with postsynaptic G protein-coupled signaling.
All drugs used are noted in the text, including concentrations. Data are re-
ported as mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and can be found with this article online at doi:10.1016/j.neuron.2012.03.035.
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